Lichen Sclerosus Treatment Market Application, Trends And Share Analysis By Type Of Treatment (Drug Therapy, Surgery), By Mode Of Administration (Topical, Oral, Iv And Others), By End Users (Hospitals, Dermatology Clinics, Pharmacies, And Others) - Forecast Till 2027
Lichen sclerosus is underdiagnosed condition of the anogenital region. It is often painful and itchy and may cause sexual and urinary dysfunction.
Prevalence of skin diseases is increasing across the globe. People are unaware of most of the rare skin diseases, which is one of the driving factors of the market. Moreover, lichen sclerosus treatment market is driven by growing prevalence of this disease in both developed and developing countries. Additionally, increasing geriatric population with skin disease, which remain untreated for a long period of time boost the market growth.
The global lichen sclerosus treatment market is expected to grow at a CAGR of 7.8% during the forecast period and is estimated to reach USD 150 million by 2023.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4265
The treatment procedures for the disease are inclusive of application of drugs and surgery. The drugs against lichen sclerosus can be administered via topical, oral, IV routes and others. Increasing prevalence of skin diseases is one of the major drivers for market growth during the forecast period. In 2013, according to the American Osteopathic College of Dermatology, American spent approximately USD 75 billion was spent on skin disease. It is estimated that anyone be diagnosed with lichen sclerosus, however, a majority of the effected population is inclusive of menopausal women. In 2015, the United Census Bureau stated that the global geriatric population for females will reach 4,139 million by 2030 from 3,601 million in 2015. Moreover, factors such as rising healthcare expenditure and increasing research and development expenses by the market key players drives the market growth. However, lack of specific treatments and lack of awareness for the disease is estimated to restraint the market growth during forecast period.
The global lichen sclerosus treatment market is expected to grow at a CAGR of 7.8% during the forecast period and is estimated to reach USD 150 million by 2023.
Key Players in the Global Lichen Sclerosus Treatment Market
Some of the key players in this market are AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Valeant Pharmaceuticals, and Zylera Pharmaceuticals.
Segments The global sclerosus treatment market is segmented on the basis of type of treatment, which includes drug therapy and surgery. The drug therapy is further segmented into corticosteroid, immune modulating drugs, retinoid like agents, and others. Surgery is further segmented into laser surgery, circumcision, and others.
On the basis of mode of administration, the market is segmented into oral, topical, IV (Intravenous), and others. Oral is further segmented into tablets, capsule, and others. The topical administration is further segmented into creams, ointment, and others.
On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmacies, and others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Comments